TickerFacts.

United Therapeutics Corp (UTHR): Net Income

Annual figures by period end, from SEC filings.

$1.33B
Year ended 2025-12-31
$1.31B
Trailing 12 months to 2026-06-30
+22.4%
3-year compound annual growth
2021-12-31: $475.80M2022-12-31: $727.30M2023-12-31: $984.80M2024-12-31: $1.20B2025-12-31: $1.33B$1.33B
2021-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$1.33B+11.7%2026-02-25, From 2025-01-01
2024-12-31$1.20B+21.4%2026-02-25, From 2024-01-01
2023-12-31$984.80M+35.4%2026-02-25, From 2023-01-01
2022-12-31$727.30M+52.9%2025-02-26, From 2022-01-01
2021-12-31$475.80Mn/a2024-02-21, From 2021-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
United Therapeutics Corp (UTHR)2025-12-31$1.33B+11.7%
BioMarin Pharmaceutical Inc (BMRN)2025-12-31$348.90M-18.3%
Amneal Pharmaceuticals, Inc. (AMRX)2025-12-31$72.06Mn/m
Alnylam Pharmaceuticals, Inc. (ALNY)2025-12-31$313.75Mn/m
Perrigo Co PLC (PRGO)2025-12-31-$1.43Bn/m
Royalty Pharma plc (RPRX)2025-12-31$770.95M-10.2%
Jazz Pharmaceuticals plc (JAZZ)2025-12-31-$356.15Mn/m
Sarepta Therapeutics, Inc. (SRPT)2025-12-31-$713.41Mn/m
Elanco Animal Health Inc (ELAN)2025-12-31-$232.00Mn/m

Compare UTHR, BMRN, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗